Deskside with Dr. Dan FDA granted accelerated approval to belantamab mafodotin-blmf for multiple myeloma Dr. Dan, Gryt Health’s Chief Medical Officer breaks down the takeaways of this new approval from January 2021. Liz Hiles July 7, 2022